← Leaderboards
Tricia Helen Burdo
Scripps Research Institute
$21,936,143
Attributed
$39,796,767
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,796,767 · 11
By mechanism
UM1$24,038,480 · 1
R01$12,096,891 · 4
R56$1,572,074 · 2
T32$1,011,475 · 1
P30$936,147 · 2
F32$141,700 · 1
Top collaborators
- Kamel Khalili7 shared
- Beau M Ances5 shared
- Katharine June Bar5 shared
- Xuebin Qin4 shared
Most similar at Scripps Research Institute
Same institution · by research overlap
- Howard S. Fox$60,934,349
- Dennis R. Burton$354,198,604
- Loren H Parsons$13,615,942
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionViralInsightHiv InfectionsAntiretroviral TherapyMonocyteMacrophageHiv-1CellsImmuneImmune ActivationMediatingMolecularInflammationMacaca MulattaAnimal ModelReportingGenesBrainPeripheralDesignPathogenesisAcquired Immunodeficiency SyndromeMultidisciplinary
Grant awards (38)
CRISPR for Cure$4,807,696
UM1 · FY2025 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing$696,272
R01 · FY2025 · MH
Cannabis, HIV and Mental Processing Systems (CHAMPS)$544,074
R01 · FY2025 · DA
CRISPR for Cure$4,807,696
UM1 · FY2024 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing$932,056
R01 · FY2024 · MH
Cannabis, HIV and Mental Processing Systems (CHAMPS)$579,913
R01 · FY2024 · DA
Component for Institution # 269291$84,158
P30 · FY2024 · MH · contact PI
CRISPR for Cure$4,807,696
UM1 · FY2023 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing$936,026
R01 · FY2023 · MH
Cannabis, HIV and Mental Processing Systems (CHAMPS)$588,418
R01 · FY2023 · DA
Component for Institution # 269291$99,521
P30 · FY2023 · MH · contact PI
CRISPR for Cure$4,807,696
UM1 · FY2022 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing$970,435
R01 · FY2022 · MH
Cannabis, HIV and Mental Processing Systems (CHAMPS)$602,794
R01 · FY2022 · DA
Interdisciplinary and Translational Research Training in NeuroHIV$398,358
T32 · FY2022 · MH · contact PI
Component for Institution # 269291$250,001
P30 · FY2022 · MH · contact PI
CRISPR for Cure$4,807,696
UM1 · FY2021 · AI
Novel macrophage-tropic transmitted/founder SHIV model of CNS persistence to evaluate CRISPR/Cas9 gene editing$1,133,540
R01 · FY2021 · MH
Cannabis, HIV and Mental Processing Systems (CHAMPS)$644,151
R01 · FY2021 · DA
Role of caspase-1 activation in HIV-1 associated atherogenesis$612,974
R01 · FY2021 · HL · contact PI
Interdisciplinary and Translational Research Training in NeuroHIV$141,075
T32 · FY2021 · MH · contact PI
Combination gene editing protocol using CRISPR technology for HIV/AIDS cure in non-human primates$824,124
R56 · FY2020 · AI · contact PI
Role of caspase-1 activation in HIV-1 associated atherogenesis$612,874
R01 · FY2020 · HL · contact PI
Interdisciplinary and Translational Research Training in NeuroHIV$472,042
T32 · FY2020 · MH · contact PI
Developmental Core$167,489
P30 · FY2020 · MH · contact PI
Bimodal gene editing strategy for HIV/AIDS cure in non-human primates$747,950
R56 · FY2019 · AI · contact PI
Role of caspase-1 activation in HIV-1 associated atherogenesis$610,461
R01 · FY2019 · HL · contact PI
Developmental Core$167,489
P30 · FY2019 · MH · contact PI
Role of caspase-1 activation in HIV-1 associated atherogenesis$646,706
R01 · FY2018 · HL
Developmental Core$167,489
P30 · FY2018 · MH · contact PI
Monocyte/macrophage traffic and peripheral nerve pathogenesis$323,651
R01 · FY2016 · NS · contact PI
Monocyte/macrophage traffic and peripheral nerve pathogenesis$431,862
R01 · FY2015 · NS · contact PI
Monocyte/macrophage traffic and peripheral nerve pathogenesis$414,777
R01 · FY2014 · NS · contact PI
Monocyte/macrophage traffic and peripheral nerve pathogenesis$396,140
R01 · FY2013 · NS · contact PI
Monocyte/macrophage traffic and peripheral nerve pathogenesis$419,767
R01 · FY2012 · NS · contact PI
CNS macrophage accumulation during NeuroAIDS$50,428
F32 · FY2006 · NS · contact PI
CNS macrophage accumulation during NeuroAIDS$48,296
F32 · FY2005 · NS
CNS macrophage accumulation during NeuroAIDS$42,976
F32 · FY2004 · NS